BioSpace News Archive

Drug Development

TauRx’s Alzheimer’s Drug Showing Positive Results in Large Clinical Trials

TauRx analyzed the relationship between the treatment doses, blood levels and pharmacological activity of the drug on the brain in more than 1,000 patients with mild-to-moderate Alzheimer’s disease as part of two Phase III global clinical trials.

November 27, 2019
·
3 min read
·
Mark Terry
Business

Azzur Group Expands With New Washington, D.C.-Area Office

Azzur Welcomes Tita Tavares as Director of Its New Office in Washington, D.C.

November 27, 2019
·
3 min read
Competitive by design

New research report estimates near-term market opportunity for emerging biosimilar markets, and examines role of drug delivery device design in competitive differentiation

November 27, 2019
·
3 min read
FDA

FDA Approves Oxbryta™ (Voxelotor), the First Medicine Specifically Targeting the Root Cause of Sickle Cell Disease

First and only FDA-approved sickle hemoglobin polymerization inhibitor, a new class of therapy

November 27, 2019
·
12 min read
SkinBioTherapeutics announces deal for development of new cosmetic skincare ingredient based on pioneering skin microbiome research

Agreement with speciality chemical company, Croda International, to design and manufacture a new active skincare ingredient based on SkinBiotix™ technology and investigate specific cosmetic ingredient applications to target.

November 27, 2019
·
4 min read
Business

PCI Biotech: Third quarter 2019 results

PCI Biotech, a cancer focused biopharmaceutical company announces its third quarter 2019 result.

November 27, 2019
·
4 min read
Policy

FDA grants priority review to Roche’s risdiplam for spinal muscular atrophy

Filing submission includes 12-month data from pivotal FIREFISH and SUNFISH trials in a broad population of people living with Types 1, 2 or 3 SMA

November 27, 2019
·
7 min read
Deals

AB Science provides the summary of webcast with Key Opinion Leaders on Indolent Systemic Mastocytosis

Summary of webcast with Key Opinion Leaders on Indolent Systemic Mastocytosis

November 27, 2019
·
11 min read
Deals

Enochian Biosciences Expands its Infectious Disease Pipeline by Entering into an Agreement in Principle to Acquire an Exclusive License for a Novel Hepatitis B Virus Treatment

Agreement provides Enochian with exclusive rights to develop and commercialize a HBV treatment with a novel mechanism of action

November 27, 2019
·
9 min read
Theratechnologies Starts Commercialization of New EGRIFTA SVᵀᴹ in the United States

Theratechnologies Inc., a commercial-stage biopharmaceutical company, is pleased to announce that EGRIFTA SVᵀᴹ is now commercially available in the United States.

November 27, 2019
·
4 min read